Linical Co., Ltd. (TYO:2183)
Japan · Delayed Price · Currency is JPY 267.00
-3.00 (-1.11%)
At close: Mar 27, 2026
Linical Market Cap
Linical has a market cap or net worth of 6.03 billion as of March 27, 2026. Its market cap has decreased by -20.06% in one year.
Market Cap
6.03B
Enterprise Value
3.23B
Revenue
9.32B
Ranking
n/a
PE Ratio
n/a
Stock Price
267.00
Market Cap Chart
Since October 27, 2008, Linical's market cap has decreased from 9.24B to 6.03B, a decrease of -34.73%. That is a compound annual growth rate of -2.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 6.03B | -8.87% |
| Dec 30, 2025 | 6.62B | -15.80% |
| Dec 30, 2024 | 7.86B | -34.34% |
| Dec 29, 2023 | 11.97B | -23.19% |
| Dec 30, 2022 | 15.58B | -11.31% |
| Dec 30, 2021 | 17.57B | 10.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MEDINET | 7.73B |
| CellSource | 7.70B |
| Carna Biosciences | 7.69B |
| Chiome Bioscience | 7.29B |
| PRISM BioLab Co.,LTD | 7.09B |
| Noile-Immune Biotech | 6.54B |
| TMS Co., Ltd. | 6.37B |
| Soiken Holdings | 6.30B |